Stabilization of phenylalanine ammonia lyase against organic solvent mediated deactivation

International Journal of Pharmaceutics

Volumn 331, Issue 1, 2007, Pages 107-115

  Shah, R M ^a   D'mello, Anil P ^a  

^a UNIVERSITY OF THE SCIENCES   (United States)

Author keywords

Catalytic activity; Cyclodextrins; Emulsion; Microcapsule; Organic solvents; Phenylalanine ammonia lyase

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; ALCOHOL; CINNAMIC ACID; ETHER; GAMMA CYCLODEXTRIN; HEMOGLOBIN A; ORGANIC SOLVENT; PHENYLALANINE; PHENYLALANINE AMMONIA LYASE; PYROXYLIN; WATER;

AQUEOUS SOLUTION; ARTICLE; DRUG INDICATION; DRUG STABILITY; EMULSION; ENZYME ACTIVATION; ENZYME INACTIVATION; ENZYME STABILITY; GEL ELECTROPHORESIS; GEL PERMEATION CHROMATOGRAPHY; MICROCAPSULE; MICROENCAPSULATION; PHENYLKETONURIA; PRIORITY JOURNAL; SIMULATION;

ADSORPTION; BETA-CYCLODEXTRINS; CAPSULES; CHROMATOGRAPHY, GEL; DRUG STABILITY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EMULSIONS; ETHANOL; ETHER, ETHYL; EXCIPIENTS; GAMMA-CYCLODEXTRINS; GLASS; HEMOGLOBINS; PHENYLALANINE AMMONIA-LYASE; SOLVENTS; TROMETHAMINE; WATER;

EID: 33846575689     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.11.044     Document Type: Article

References (29)

1. Albers E., and Muller B.W. Cyclodextrin derivatives in pharmaceutics. Crit. Rev. Ther. Drug Carrier Syst. 12 (1995) 311-337
2. Bourget L., and Chang T.M. Artificial cell-microencapsulated phenylalanine ammonia-lyase. Appl. Biochem. Biotechnol. 10 (1984) 57-59
3. Bourget L., and Chang T.M. Phenylalanine ammonia-lyase immobilized in semipermeable microcapsules for enzyme replacement in phenylketonuria. FEBS Lett. 180 (1985) 5-8
4. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
5. Brewster M.E., Hora M.S., Simpkins J.W., and Bodor N. Use of 2-hydroxypropyl-beta-cyclodextrin as a solubilizing and stabilizing excipient for protein drugs. Pharm. Res. 8 (1991) 792-795
6. Brown R.E., Jarvis K.L., and Hyland K.J. Protein measurement using bicinchoninic acid: elimination of interfering substances. Anal. Biochem. 180 (1989) 136-139
7. Curzon G., and Vallet L. The purification of human caeruloplasmin. Biochem. J. 74 (1960) 279-287
8. Ding Z., Harding C.O., and Thony B. State-of-the-art 2003 on PKU gene therapy. Mol. Genet. Metab. 81 (2004) 3-8
9. Frantzen F., Grimsrud K., Heggli D., and Sundrehagen E. Selective precipitation of human hemoglobin by organic solvents and metal cations. Hemoglobin 21 (1997) 155-172
10. Gamez A., Wang L., Straub M., Patch M.G., and Stevens R.C. Toward PKU enzyme replacement therapy: PEGylation with activity retention for three forms of recombinant phenylalanine hydroxylase. Mol. Ther. 9 (2004) 124-129
11. Habibi-Moini S., and D'mello A.P. Evaluation of possible reasons for the low phenylalanine ammonia lyase activity in cellulose nitrate membrane microcapsules. Int. J. Pharm. 215 (2001) 185-196
12. Halling P.J. Thermodynamic predictions for biocatalysis in nonconventional media: theory, tests, and recommendations for experimental design and analysis. Enzyme Microbial Technol. 16 (1994) 178-206
13. Hanley W.B. Adult phenylketonuria. Am. J. Med. 117 (2004) 590-595
14. Hickel A., Radke C.J., and Blanch H.W. Role of organic solvents on Pa-hydroxynitrile lyase interfacial activity and stability. Biotechnol. Bioeng. 74 (2001) 18-28
15. Hoskins J.A., Jack G., Wade H.E., Peiris R.J., Wright E.C., Starr D.J., and Stern J. Enzymatic control of phenylalanine intake in phenylketonuria. Lancet 1 (1980) 392-394
16. Khmelnitsky Y.L., Mozhaev V.V., Belova A.B., Sergeeva M.V., and Martinek K. Denaturation capacity: a new quantitative criterion for selection of organic solvents as reaction media in biocatalysis. Eur. J. Biochem. 198 (1991) 31-41
17. Khot, A., 2005. Evaluation of the purity of commercially available phenylalanine ammonia lyase and variables affecting its encapsulation efficiency in cellulose nitrate microcapsules. MS Thesis. University of the Sciences in Philadelphia, Philadelphia, United States of America.
18. Kim W., Erlandsen H., Surendran S., Stevens R.C., Gamez A., Michols-Matalon K., Tyring S.K., and Matalon R. Trends in enzyme therapy for phenylketonuria. Mol. Ther. 10 (2004) 220-224
19. Lee W.K., McGuire J., and Bothwell M.K. Competitive adsorption of bacteriophage T4 lysozyme stability variants at hydrophilic glass surfaces. J. Coll. Interf. Sci. 269 (2004) 251-254
20. Meinel L., Illi O.E., Zapf J., Malfanti M., Peter Merkle H., and Gander B. Stabilizing insulin-like growth factor-I in poly(d,l-lactide-co-glycolide) microspheres. J. Control Release 70 (2001) 193-202
21. Morlock M., Koll H., Winter G., and Kissel T. Microencapsulation of rh-erythropoietin, using biodegradable poly(Image, Image-lactide-co-glycolide): protein stability and the effects of stabilizing excipients. Eur. J. Pharm. Biopharm. 43 (1996) 29-36
22. 2 interface: enzyme unfolding and aggregation and its prevention by polyols. J. Pharm. Pharmacol. 53 (2001) 1217-1226
23. Sah H. Protein instability toward organic solvent/water emulsification: implications for protein microencapsulation into microspheres. PDA J. Pharm. Sci. Technol. 53 (1999) 3-10
24. Sah H. Stabilization of proteins against methylene chloride/water interface-induced denaturation and aggregation. J. Control Release 58 (1999) 143-151
25. Simon L.M., Kotorman M., Garab G., and Laczko I. Structure and activity of alpha-chymotrypsin and trypsin in aqueous organic media. Biochem. Biophys. Res. Commun. 280 (2001) 1367-1371
26. Stevenson C.L. Characterization of protein and peptide stability and solubility in non-aqueous solvents. Curr. Pharm. Biotechnol. 1 (2000) 165-182
27. Vinogradov A.A., Kudryashova E.V., Grinberg V.Y., Grinberg N.V., Burova T.V., and Levashov A.V. The chemical modification of alpha-chymotrypsin with both hydrophobic and hydrophilic compounds stabilizes the enzyme against denaturation in water-organic media. Protein Eng. 14 (2001) 683-689
28. Wu C.S., and Chen G.C. Adsorption of proteins onto glass surfaces and its effect on the intensity of circular dichroism spectra. Anal. Biochem. 177 (1989) 178-182
29. Zannou E.A., Streng W.H., and Stella V.J. Osmotic properties of sulfobutylether and hydroxypropyl cyclodextrins. Pharm. Res. 18 (2001) 1226-1231